Breaking News
September 26, 2018 - New insights into what drives organ transplant rejection
September 26, 2018 - Tiny Device Is a ‘Huge Advance’ for Treatment of Severe Heart Failure
September 26, 2018 - Research shows possibility to postpone cumbersome treatment for low-risk MDS patients
September 26, 2018 - CSU chemists may help in making extracorporeal life support devices more effective
September 26, 2018 - Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer’s disease
September 26, 2018 - PCORI, AHRQ announce awards to support patient-centered outcomes research in learning health systems
September 26, 2018 - Scientists discover and characterize human skeletal stem cells
September 26, 2018 - Repeat CT Common in Peds Traumatic Epidural Hematoma
September 26, 2018 - Genetics Home Reference: bunion
September 26, 2018 - Increase observed in hearts from drug-intoxicated donors
September 26, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 26, 2018 - TINY cancer detection device shows promise as point-of-care detector of KSHV
September 26, 2018 - Women with non-small cell lung cancers live longer than their male counterparts
September 26, 2018 - KTU researchers engineer experimental bone to help treat osteoarthritis patients
September 26, 2018 - Foundation for a Smoke-Free World calls for proposals to implement Smoke-Free Index
September 26, 2018 - Functional Imagery Training helps lose five times more weight than talking therapy
September 26, 2018 - Fewer American Teens Having Sex, Most Using Birth Control
September 26, 2018 - We are predisposed to forgive, new research suggests
September 26, 2018 - Insomnia Exacts Heavy Toll on Quality of Life
September 26, 2018 - Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility
September 26, 2018 - Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s
September 26, 2018 - Study finds persistent rate of lawnmower injury-related emergency department visits
September 26, 2018 - Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson’s disease
September 26, 2018 - Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award
September 26, 2018 - New spinout company to tackle drug-resistant infections with novel antibiotics
September 26, 2018 - In depression the brain region for stress control is larger
September 26, 2018 - Smuggling RNA into cells can activate the immune system to fight cancer
September 26, 2018 - Special Focus Issue takes wide view of complementary and integrative medicine in cancer
September 26, 2018 - Researchers now confirm that genome duplication drives evolution of species
September 25, 2018 - Study provides evidence of beta lactamase producing, antimicrobial resistant E. coli in U.S. retail meat
September 25, 2018 - UCI study finds new cause of cerebral microbleeds
September 25, 2018 - Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders
September 25, 2018 - Chinese and German researchers to cooperate more closely in future for better food
September 25, 2018 - Recent study helps predict probability of pregnant mothers to have child with autism
September 25, 2018 - New online, sound matching tool offers tinnitus sufferers potential treatment options
September 25, 2018 - UC Davis researchers take critical step in developing more effective Salmonella vaccine
September 25, 2018 - Antibiotics best paediatric treatment for children’s chronic wet cough
September 25, 2018 - Looking beyond opioids: Stanford pain psychologist briefs Congress
September 25, 2018 - Organs actively fighting back against autoimmune diseases, finds study
September 25, 2018 - Lancaster professor aims to understand how genes affect smoking cessation
September 25, 2018 - Human-oriented perspective needed to better understand Parkinson’s disease
September 25, 2018 - Physical activity may have beneficial effects for people with rare Alzheimer’s disease
September 25, 2018 - FDA Updates on Valsartan Recalls
September 25, 2018 - 3-D-printed tracheal splints used in groundbreaking pediatric surgery
September 25, 2018 - Who is the designated driver, or proxy, for your health decisions?
September 25, 2018 - New chemo-optogenetic method enables multi-directional activity control of cellular processes
September 25, 2018 - Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
September 25, 2018 - NeoTract presents new clinical data from studies of UroLift System for patients with BPH
September 25, 2018 - Patients with paralysis manage to walk thanks to new technology
September 25, 2018 - Statins Improve Long-Term Survival After AAA Repair
September 25, 2018 - Novel brain network linked to chronic pain in Parkinson’s disease
September 25, 2018 - Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
September 25, 2018 - Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
September 25, 2018 - FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
September 25, 2018 - IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
September 25, 2018 - Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
September 25, 2018 - How to Protect Your Eyesight
September 25, 2018 - Novel approach allows researchers to define how cells in the retina respond to diabetes
September 25, 2018 - Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
September 25, 2018 - New model enables anyone to run powerful simulations, complex calculations easily
September 25, 2018 - Clinical trial investigators found non-compliant with requirement to report results on EU register
September 25, 2018 - Study analyzes quality of protein supplements in function of source, treatment and storage
September 25, 2018 - FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome
September 25, 2018 - U.S. Alzheimer’s Cases to Nearly Triple by 2060
September 25, 2018 - Improving cell replacement therapy for Parkinson’s disease
September 25, 2018 - Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
September 25, 2018 - FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
September 25, 2018 - New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - ‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
September 25, 2018 - Global leaders must make bold commitments at first-ever UN tuberculosis summit
September 25, 2018 - Brief sleep intervention works long-term to prevent child obesity
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s

Are HIV and AIDS Poised for a Comeback?

image_pdfDownload PDFimage_print

WEDNESDAY, Oct. 25, 2017 — The advent of powerful drugs in the mid-1990s brought remarkable gains in survival for HIV patients who had access to the medications.

But a team of experts now warns that the global HIV pandemic continues and is at risk of expanding, given the worrisome global rise of HIV resistance to antiretroviral (ART) medications.

“Current trends in HIV drug resistance are very concerning,” said Dr. Chris Beyrer, lead author of an overview on the state of global HIV drug resistance.

“Resistance levels have been found to be highest in ART-exposed infants and children,” he added. “Which is a real concern, since children are already among the least-treated age group in many developing countries.”

Beyrer is professor of epidemiology with the Johns Hopkins Bloomberg School of Public Health in Baltimore.

He and his colleagues noted that roughly 19.5 million HIV patients — or approximately half the global population of HIV patients — are now being treated with ART.

The United Nations and the World Health Organization aim to eliminate AIDS as a public health threat by the year 2030. On the way to that goal, both organizations want to make sure that 90 percent of all HIV patients gain access to ART by 2020.

That will be “enormously difficult,” said Beyrer.

For one, WHO and experts from the U.S. Centers for Disease Control and Prevention acknowledged that ART effectiveness is increasingly at risk, with HIV drug resistance having shot up from just 11 percent in 2001 to 29 percent today.

Why? The review team noted that the “Achilles’ heel” is shoddy adherence to ART regimens, mostly because of insufficient education and insufficient access to the medications. Poor adherence allows the HIV virus to mutate and develop drug resistance.

To tackle the issue, the research team advocates placing more focus on prevention by hastening the development of an effective vaccine and by ratcheting up the use of Truvada, the HIV prevention regimen also known as PrEP. PrEP combines two ART drugs (tenofovir and emtricitabine), and the CDC says it can curtail HIV infection risk by as much as 90 percent.

At the same time, Beyrer said, those already infected but not yet treated should be given access to newer types of ART “cocktails,” including drugs such as dolutegravir that have “higher genetic barriers to resistance.”

That move alone, said Beyrer, would be “likely to have a major impact on resistance levels in the countries which go this route.”

Drug resistance may ultimately also pose a risk for PrEP, though for the time being Beyrer characterizes PrEP resistance as “very rare.”

“We need to be vigilant about this from a surveillance perspective,” he said, “but PrEP users should adhere to regimens today with confidence.”

Beyrer and his colleagues highlighted another concern: a looming threat by the U.S. government to sharply curtail global health funding.

“The proposed cuts from the Trump administration would have a severe impact on HIV treatment programs,” he said, “particularly in the poorest and highest prevalence countries in Africa, and of course in underserved communities in the U.S.”

“The Congress has so far resisted these cuts,” Beyrer added, “and we can only hope they continue to prioritize the support we need to finally control the HIV epidemic.”

Dr. Annette Sohn, from the global AIDS research advocacy organization amfAR, said she “agrees with the author’s [Beyrer’s] concerns around the current trends in resistance and their characterization of these as alarming.”

Sohn is based in Bangkok and serves as vice president of Global Initiatives for amfAR.

“To achieve true global success in preventing resistance,” she said, “we will need to create access to the best regimens for all people living with HIV.

“The proposed cuts to global HIV programs are of primary concern in this regard,” said Sohn. By doing so “we risk people losing access to treatment and stopping their medicines, which will lead to treatment failure, more new HIV infections, and increased drug resistance,” she added.

“Instead of cutting federal funding for HIV research,” Sohn said, “we need more support for implementation research to study how to optimally deliver testing and treatment services in cost-effective ways.”

The review is published in the Oct. 26 issue of the New England Journal of Medicine.

More information

There’s more on HIV drug resistance at U.S. Department of Health and Human Services.

©2017 HealthDay.

All rights reserved.

Posted: October 2017

Recommended for you

Tagged with:

About author

Related Articles